CDK7 and glioblastoma: Furthermore, flavopiridol, a CDK7/9 inhibitor, caused substantial phosphorylation of AKT in human glioblastoma cells, indicating that inhibition of CDKs might result in PI3K-AKT pathway activation, which may lead to cell survival or protection from apoptosis59.